Skip to content

Evaluation of Diabetes Self-Management Consultant Care

Evaluation of Diabetes Self-Management Consultant Care

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00109720
Enrollment
310
Registered
2005-05-03
Start date
2002-08-31
Completion date
2007-07-31
Last updated
2010-01-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Keywords

Diabetes, Self Management, Type 2 diabetes

Brief summary

The purpose of this study is to find out if Self-Management Consultant (SMC) intervention will be more effective than usual care in improving blood glucose control and diabetes-related quality of life for adults with type 2 diabetes.

Detailed description

This study is designed to compare the effectiveness of a diabetes Self-Management Consultant (SMC) intervention for adults with type 2 diabetes with unsatisfactory glucose control (i.e., HbA1c ≥ 8%--the value chosen as high risk by the Diabetes Quality Improvement Project which is an initiative of the Health Care Financing Administration, the American Diabetes Association, and the Foundation for Accountability) to a control group selected using the same criteria. The SMC intervention will be implemented and evaluated in two different health care systems serving two distinct populations of patients with diabetes. After signing the Informed Consent document, subjects will be randomized to the SMC intervention or a control group. All subjects in the study will complete a baseline assessment of their diabetes care and health status. Subjects randomized to the SMC intervention will have an individual meeting with the SMC to review and refine a self-management plan based on the subject's priorities and goals. These subjects will receive individual follow-up and support during the year, through monthly phone calls and an annual meeting with the SMC and their primary care physician. Subjects randomized to the control group will receive usual care following their baseline and their 12-, 24-, and 36-month assessments. Unlike most nurse-manager studies, the SMC's interactions with patient care will use a theory-based behavioral approach with which we have extensive experience. The study is designed to evaluate the effectiveness of the SMC intervention compared to usual care. All records will be handled confidentially. Lab results and personal data will be linked by a research specific identifier code.

Interventions

BEHAVIORALDiabetes Self-Management Consultant

services of a Diabetes Self-Management Consultant

BEHAVIORALEnhanced Usual Care Control Group

Usual care plus results of metabolic assessments obtained during the study

Sponsors

Detroit Department of Health
CollaboratorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Lead SponsorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults over age 21 diagnosed with type 2 diabetes for at least one year.

Exclusion criteria

* Patients under psychiatric care * Currently pregnant * Those who have not been diagnosed with type 2 diabetes

Design outcomes

Primary

MeasureTime frame
Blood glucose leveltwo years

Secondary

MeasureTime frame
Diabetes Related Quality of lifetwo years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026